A detailed history of American Portfolios Advisors transactions in Veracyte, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 8,818 shares of VCYT stock, worth $342,932. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,818
Holding current value
$342,932
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$16.58 - $27.9 $146,202 - $246,022
8,818 New
8,818 $146 Million
Q2 2022

Mar 20, 2023

SELL
$15.45 - $29.52 $803 - $1,535
-52 Reduced 0.59%
8,766 $174 Million
Q1 2022

Mar 21, 2023

SELL
$21.94 - $42.51 $5,814 - $11,265
-265 Reduced 3.01%
8,553 $236 Million
Q4 2021

Mar 21, 2023

SELL
$36.09 - $53.79 $33,130 - $49,379
-918 Reduced 10.41%
7,900 $325 Million

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.78B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.